MetLife Analysts Recommendations and Consensus

MET -- USA Stock  

USD 48.45  0.78  1.64%

The current analyst and expert consensus on MetLife is Buy with 0 strong sell and 6 strong buy opinions. The current projected target price consensus is 55.88 with 8 analysts opinions. The most common way MetLife analysists use to provide recommendation to public is financial statements analysis. Many experts also interview MetLife executives and customers to further validate their buy or sell advice. MetLife buy or sell recommendation module provides average expert sentiment on the projected MetLife target price to derive its highest and lowest estimates based on projected price volatility of 6.49. Please see also Macroaxis Advice on MetLife to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

MetLife Target Price Consensus

Number of Opinions11
Lowered Outlook0
Raized Outlook0
Buy
Macroaxis Recommendation   Exposure   Valuation

MetLife Target Price Projection

Current Price

MetLife Market Quote
Low Price47.79Odds
High Price48.46Odds

48.45

Target Price

Analyst Consensus On Target Price
Low Estimate44.0Odds
High Estimate62.0Odds
Number of Analysts8
Standard Deviation6.49

55.875

MetLife Analysit Ratings

Average Consensus

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Current Thematic Trending
Millennials Best
Purchased over 90 shares
Traded a day ago for 106.18
Consumer Goods
Purchased over 90 shares
Traded a day ago for 4.3
Beer and Liquor
Purchased over 90 shares
Traded a day ago for 120.36
Consumer Goods
Sold over 90 shares
Traded a day ago for 144.71
Petroleum
Purchased over 90 shares
Traded a day ago for 52.08
Top FinTech
Purchased over 90 shares
Traded a day ago for 64.14
Please see also Macroaxis Advice on MetLife to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.